Akasaka T, Yoshida K, Yamamuro A, Hozumi T, Takagi T, Morioka S, Yoshikawa J
Department of Cardiology, Kobe General Hospital, Japan.
Circulation. 1997 Sep 16;96(6):1874-81. doi: 10.1161/01.cir.96.6.1874.
Phasic coronary flow characteristics have been reported in patients with aortic valve disease and hypertrophic cardiomyopathy. The purpose of this study was to assess the differences in coronary flow characteristics between patients with constrictive pericarditis and those with restrictive cardiomyopathy.
The study populations consisted of 7 case patients with constrictive pericarditis, 8 with restrictive cardiomyopathy, and 11 control subjects with chest pain and normal coronary arteries. Five minutes after injection of 3 mg of isosorbide dinitrate, phasic coronary flow velocity patterns were analyzed in the proximal segment of the angiographically normal left anterior descending coronary artery at rest using a 0.014-in, 15-MHz Doppler guidewire. Coronary flow reserve was obtained from the ratio of adenosine-induced (0.14 mg x kg(-1) x min(-1) I.V.) hyperemic/baseline time-averaged peak velocity. Although in case patients with constrictive pericarditis and restrictive cardiomyopathy maximal hyperemic time-averaged peak velocity (21+/-8 and 31+/-17 versus 60+/-19 cm/s, respectively; P<.001) and coronary flow reserve (1.3+/-0.4 and 1.6+/-0.6 versus 3.6+/-0.4, respectively, P<.001) were significantly lower than in control subjects, there were no significant differences in these indexes between the two groups of case patients. Velocity half-time of diastolic flow velocity corrected by square root(RR), which indicates deceleration of diastolic flow, in the groups of case patients with constrictive pericarditis and restrictive cardiomyopathy was significantly less than that in control subjects (6.2+/-2.6 and 10.6+/-1.5 versus 16.9+/-2.7, respectively; P<.001); this was also significantly smaller in constrictive pericarditis than restrictive cardiomyopathy (P<.001). This index <9.5 could distinguish constrictive pericarditis from restrictive cardiomyopathy with a sensitivity of 86% and a specificity of 88%. Furthermore, time from the beginning of diastole to diastolic peak velocity corrected by square root(RR) indicating acceleration of diastolic flow velocity in constrictive pericarditis was significantly less than that in restrictive cardiomyopathy and control subjects (2.8+/-1.2 versus 4.8+/-0.8 and 4.4+/-0.6, respectively; P<.001).
Although coronary flow reserve is limited in both constrictive pericarditis and restrictive cardiomyopathy because of restriction of hyperemic response, rapid acceleration and more rapid deceleration of diastolic flow velocity are more characteristic in constrictive pericarditis than in restrictive cardiomyopathy.
已有报道称主动脉瓣疾病和肥厚型心肌病患者存在阶段性冠状动脉血流特征。本研究的目的是评估缩窄性心包炎患者与限制型心肌病患者在冠状动脉血流特征方面的差异。
研究人群包括7例缩窄性心包炎患者、8例限制型心肌病患者以及11例有胸痛且冠状动脉正常的对照者。注射3mg硝酸异山梨酯5分钟后,使用0.014英寸、15MHz的多普勒导丝,在静息状态下对血管造影正常的左前降支冠状动脉近端节段的阶段性冠状动脉血流速度模式进行分析。冠状动脉血流储备通过腺苷诱导(静脉注射0.14mg·kg⁻¹·min⁻¹)充血/基础时间平均峰值速度的比值获得。尽管缩窄性心包炎和限制型心肌病患者的最大充血时间平均峰值速度(分别为21±8和31±17,而对照者为60±19cm/s;P<0.001)和冠状动脉血流储备(分别为1.3±0.4和1.6±0.6,而对照者为3.这两组病例患者之间在这些指标上无显著差异。缩窄性心包炎和限制型心肌病患者组中,经平方根(RR)校正的舒张期血流速度的速度半衰期,即表示舒张期血流减速的指标,显著低于对照者(分别为6.2±2.6和10.6±1.5,而对照者为16.9±2.7;P<0.001);在缩窄性心包炎中该指标也显著小于限制型心肌病(P<0.001)。该指标<9.5可区分缩窄性心包炎与限制型心肌病,敏感性为86%,特异性为88%。此外,缩窄性心包炎中从舒张期开始到经平方根(RR)校正的舒张期峰值速度的时间,即表示舒张期血流速度加速的时间,显著短于限制型心肌病和对照者(分别为2.8±1.2,而限制型心肌病为4.8±0.8,对照者为4.4±0.6;P<0.001)。
尽管由于充血反应受限,缩窄性心包炎和限制型心肌病的冠状动脉血流储备均有限,但缩窄性心包炎中舒张期血流速度的快速加速和更快减速比限制型心肌病更具特征性。